Resolute Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.2K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $99.2K | Hold |
|
|||||
|
2024
Q3 | $96.7K | Hold |
|
|||||
|
2024
Q2 | $110K | Hold |
|
|||||
|
2024
Q1 | $146K | Hold |
|
|||||
|
2023
Q4 | $145K | Hold |
|
|||||
|
2023
Q3 | $112K | Buy |
|
|||||
|
2023
Q2 | $82.2K | Hold |
|
|||||
|
2023
Q1 | $73.4K | Hold |
|
|||||
|
2022
Q4 | $84.8K | Hold |
|
|||||
|
2022
Q3 | $117K | Buy |
|
|||||
|
2022
Q2 | $75K | Hold |
|
|||||
|
2022
Q1 | $66K | Hold |
|
|||||
|
2021
Q4 | $157K | Buy |
|